 FSD Pharma Inc NASDAQ: HUGE has netted itself more than 7.7 million through the sale of its 12 equity interest in Cannara Biotech Inc OTC: LOVFF to a consortium of that included entities controlled by members of the Cannara board and senior management. A substantial portion of FSD Pharmas stake in Cannara was subject to a statutory escrow expiring December 2021. Under the terms of the deal, the buyers agreed to acquire FSD Pharmas interest subject to escrow and, as such, assumed all of the associated market risk. 